RE:RE:RE:Echelon Partners 100 after 2.5 weeks.
Prescriptions accelerating.
1st week of July is 7 weeks away.
I’ll go with 450-500 prescriptions.
Is that not just the low hanging Fuzeon fruit anyway?
bfw
palinc2000 wrote: SPCEO1 wrote: SPCEO1 wrote: Bloomberg is reporting that Echelon published something today but the analyst did not change wither his target price of C$12.50 or his Buy recommendation. Since those two things don't add up, I suspect we will see one of them change soon.
I believe a short, positive note in his weekly report is what Bloomberg was picking up. In it, the Echelon analyst seemed to indicate he would be waiting until Q2 results are reported before making any changes to his model or rating. But that is me reading between the lines, which doesn't always provide accurate results. After the stock's big run, it may well consolidate a bit and ease the pressure on this analyst to address the obvious problem with his Buy rating, his target price and the current stock price. However, if the stock price is stable or rises further, I am not sure he can postpone addressing the problem until early July. The same is true for the Canaccord analyst. CIBC has a target price of C$15, so his rating still makes sense. NBF at C$14 barely makes any sense. Mackie at C$19.50 has a price target that more comport both with reality and his rating.
If we had from TH something similar to the Federal Reserve Dot Plot that would make analysts job much easier and ours also.But that wont happen!! However I believe if we are provided with enough dots that we will be in a position to evaluate the steepness of the demand curve For now all we have is about 100 patients on May 16 ....We should be provided additional dots for end of May and possibly for first week of July during the CC Can anyone venture what the cumulative number of patients will be in the first week of July.?